Navigation Links
CMC Contrast Granted Orphan Drug Designation by the FDA for its Liver Specific MRI Contrast Media CMC-001
Date:11/27/2013

LUND, Sweden, November 27, 2013 /PRNewswire/ --

CMC Contrast AB, a privately owned drug development company that is developing a targeted contrast agent for Magnetic Resonance Imaging (MRI), announced today that Orphan Drug Designation has been granted by the US Food and Drug Administration (FDA) for its liver specific contrast agent CMC-001. The Orphan Drug Designation has been granted for CMC-001 for use as a targeted contrast agent for diagnostic MRI for detection and localization of focal liver lesions in patients where gadolinium-based contrast agents are contraindicated or cannot be administered.

Orphan Drug Designation is granted by the FDA Office of Orphan Drug Products to novel drugs intended to treat a rare disease or condition affecting fewer than 200,000 people in the U.S. The designation confers special incentives to the drug developer, including tax credits towards the cost of clinical trials, prescription drug user fee waivers and may entitle a period of seven years U.S market exclusivity upon FDA approval.

Magnus Corfitzen, Chairman of CMC Contrast AB "The diagnostic benefits of enhanced MRI liver imaging in detecting and localizing focal liver lesions are well established. However, a small subset of patient groups cannot undergo enhanced liver MRI procedures due to the risks of severe side effects associated with currently used gadolinium based contrast agents. For these patients, including patients with severe chronic renal insufficiency, important diagnostic information may be missed due to lack of contrast enhanced MRI. CMC-001 will allow radiologists to obtain the best possible diagnostic information in these subsets of patients, enabling clinicians to select the optimal treatment option for these patients. This is not possible today as clinicians only have access to data from an unenhanced imaging procedure on which they will base their disease management decisions for these patients"

The
'/>"/>

SOURCE CMC Contrast
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Medical Imaging Markets: Contrast Agents
2. Radiopharmaceuticals and Contrast Media: Frost & Sullivan Predicts Market Growth in Europe
3. Diagnostic Imaging Covers Communicating Contrast Agent Risk
4. Contrasting Reimbursement Environments Result in Different Prescribing Patterns for Premium-Priced Therapies in China and South Korea
5. Inovio Pharmaceuticals Granted U.S. Patent Protection for Synthetic Vaccine for Cervical Dysplasia and Cancer
6. Broad Patent Protection Granted for iBio Immunomodulator
7. BiO2 Medical Granted CE Mark for the Angel™ Catheter, the First IVC Filter with a Prophylactic Use Indication
8. QRxPharma Granted Additional US Patent on MoxDuo®
9. Oramed Pharmaceuticals Granted Core Technology Patent in New Zealand
10. Unilife Granted Key U.S. Patent for Unifill Prefilled Syringe
11. Vomaris patent estate grows to six issued U.S. patents and three granted international patents with U.S. Pat. No. 8,224,439
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/22/2014)... 22, 2014 Decision Resources Group finds that by ... to be worth $2 billion (U.S. dollars), increasing at a ... five years (to 2018). This growth comes as ... 2013 and 4.9 percent expected over the next three to ... small but highly competitive. The pharmaceutical market is dominated by ...
(Date:9/22/2014)... 2014  Aethlon Medical, Inc. (OTCQB: AEMD), the ... infectious disease, cancer and other life-threatening conditions, disclosed ... (DARPA) has informed the Company that it plans ... four of a five-year $5.9 million contract that ... under DARPA,s Dialysis-Like Therapeutics (DLT) program. ...
(Date:9/22/2014)... , Sept. 22, 2014  Neuralstem, Inc. (NYSE MKT: CUR) ... investigator at Emory University, presented long-term follow up data ... stem cells in the treatment of amyotrophic lateral sclerosis ... which occurred at the Annual Symposium on ALS of ... , on Friday, and was not open to the ...
Breaking Medicine Technology:Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 2Despite Its Limited Size, Chile's Pharmaceutical Market Offers Growing Opportunity for Drug Industry 3Aethlon Medical Receives Notice of DARPA Contract Renewal 2Aethlon Medical Receives Notice of DARPA Contract Renewal 3Aethlon Medical Receives Notice of DARPA Contract Renewal 4Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 2Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 3Neuralstem ALS Investigator Presents Long-Term Follow Up Phase I Data 4
... One out of three U.S. adults plan to skip ... Medical telephone poll. Against that backdrop, two top clinical leaders ... American public that influenza season can be a deadly time ... asthma or COPD (Chronic Obstructive Pulmonary Disease). Such patients need ...
... One week after a CDC report outlined the devastating ... which causes 8,000 U.S. deaths and costs billions of ... of patients, families, advocates, physicians and scientists, last night ... discoveries and unique contributions to the field of dermatology ...
Cached Medicine Technology:Poll: One Out of Three U.S. Adults Not Planning to Get Flu Shot This Year 2American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville 2American Skin Association Honors Leading Physicians and Scientists; Journalist Deborah Norville 3
(Date:9/22/2014)... IsoComforter, Inc., one of the Nation’s premier ... of an innovative IsoTube technology and uniflow technology that ... ridges provide optimal contact and pain control. By utilizing ... fluid reservoir to a pad that is applied to ... continuous cold therapy for an extended period of time ...
(Date:9/22/2014)... (PRWEB) September 22, 2014 Follow ... diagnostic procedure that provides quantitative measurement of bone density ... is driven by the rapidly aging world population, and ... The elderly represent potential candidates for measurement of bone ... of bone tissue as a result of the natural ...
(Date:9/22/2014)... the proverbial needle in the cancer antigen haystack, according ... of Experimental Medicine . , As cancer ... creates new versions of proteins, some of which are ... cells, prompting the cells to attack and eliminate the ... of the mutations in a patient,s cancer and to ...
(Date:9/22/2014)... Researchers have found that environment has a much ... a severe, often painful food allergy that renders ... foods. , Eosinophils are normal cellular components ... too many eosinophils they can cause a variety ... inflammation and resulting tissue damage, often in the ...
(Date:9/22/2014)... to be an old acquaintance: a certain module of ... considered an anchor protein. The researchers report their findings ... importing enzymes into peroxisome , Peroxisomes are of ... acids and cellular toxins. In order for them to ... imported into the peroxisomes first. The bulk is brought ...
Breaking Medicine News(10 mins):Health News:IsoComforter Cold Therapy Introduces Innovative IsoTube Technology 2Health News:Rising Incidence of Osteoporosis Spurs Growth in the Global Bone Densitometers Market, According to New Report by Global Industry Analysts, Inc. 2Health News:Rising Incidence of Osteoporosis Spurs Growth in the Global Bone Densitometers Market, According to New Report by Global Industry Analysts, Inc. 3Health News:Environment plays bigger role than genetics in food allergic disease eosinophilic esophagitis 2Health News:The accelerator of molecular motors 2
... scientists at the Johns Hopkins School of Public Health has ... called for urgent research into the impact of soya on ... in soya can damage the male reproductive organs. Though there ... on humans, its effects on rats were so severe that// ...
... a study published in the British Medical Journal, older people ... The researchers from Cambridge, UK, identified a group of 2,686 ... sent either one capsule of Vitamin D3 or a placebo ... to provide them with information on bone fractures// and any ...
... prevalent diseases in our society with more than five million ... According to a major study in the UK, in which ... across the UK, asthma sufferers are dying needlessly because they ... compared levels of asthma control and the need and number ...
... reached epidemic proportions the world over, with India being ... the many serious diseases that diabetics can be affected ... deterioration of nerves in the body. A diabetic patient ... one or more amputations. It has been found that ...
... appetite control, called ghrelin, has been identified by researchers ... demonstrated the effect of the hormone on the brain ... neurons in the hypothalamus involved in weight regulation. Ghrelin ... ability to stimulate feeding when introduced to specialized weight ...
... skin cancer and it has been shown through previous research ... whose UV rays cause damage to DNA that triggers cancer. ... more prone than others to melanoma. Researchers have now found ... with melanoma that those with fair skin// have lowered DNA ...
Cached Medicine News:Health News:Scientists locate key hormone involved in appetite control 2
... chairs with concave seats and standard-sized ... options like seats, backrests, armrests, and ... are recommended for the following environments: ... control, health care and office. • ...
... Basic ergonomic chairs with concave seats ... • Select options like seats, backrests, ... BTT/1P chairs are recommended for the ... room, static control, health care and ...
... ergonomic chairs with concave seats and ... Select options like seats, backrests, armrests, ... chairs are recommended for the following ... static control, health care and office. ...
... ergonomic chairs with concave seats ... support • Select options like ... and glides. • BTT/1P chairs ... environments: industry, education, laboratory, clean ...
Medicine Products: